| Year |
Citation |
Score |
| 2023 |
Norbert ME, Cuffel A, Riou G, Jean L, Blondel C, Dehayes J, Bisson A, Giverne C, Brotin E, Denoyelle C, Poulain L, Boyer O, Martinet J, Latouche JB. Development of optimized cytotoxicity assays for assessing the antitumor potential of CAR-T cells. Journal of Immunological Methods. 113603. PMID 38147898 DOI: 10.1016/j.jim.2023.113603 |
0.303 |
|
| 2023 |
Sugita M, Yamazaki T, Alhomoud M, Martinet J, Latouche JB, Golden E, Boyer O, Van Besien K, Formenti SC, Galluzzi L, Guzman ML. Radiation therapy improves CAR T cell activity in acute lymphoblastic leukemia. Cell Death & Disease. 14: 305. PMID 37142568 DOI: 10.1038/s41419-023-05829-6 |
0.307 |
|
| 2020 |
Golinski ML, Demeules M, Derambure C, Riou G, Maho-Vaillant M, Boyer O, Joly P, Calbo S. CD11c B Cells Are Mainly Memory Cells, Precursors of Antibody Secreting Cells in Healthy Donors. Frontiers in Immunology. 11: 32. PMID 32158442 DOI: 10.3389/Fimmu.2020.00032 |
0.315 |
|
| 2019 |
Hébert V, Petit M, Maho-Vaillant M, Golinski ML, Riou G, Derambure C, Boyer O, Joly P, Calbo S. Modifications of the Transcriptomic Profile of Autoreactive B Cells From Pemphigus Patients After Treatment With Rituximab or a Standard Corticosteroid Regimen. Frontiers in Immunology. 10: 1794. PMID 31440235 DOI: 10.3389/Fimmu.2019.01794 |
0.343 |
|
| 2019 |
Couture A, Garnier A, Docagne F, Boyer O, Vivien D, Le-Mauff B, Latouche JB, Toutirais O. HLA-Class II Artificial Antigen Presenting Cells in CD4 T Cell-Based Immunotherapy. Frontiers in Immunology. 10: 1081. PMID 31156634 DOI: 10.3389/Fimmu.2019.01081 |
0.432 |
|
| 2019 |
Anquetil C, Boyer O, Wesner N, Benveniste O, Allenbach Y. Review: Myositis-specific autoantibodies, a cornerstone in immune-mediated necrotizing myopathy. Autoimmunity Reviews. PMID 30639649 DOI: 10.1016/J.Autrev.2018.09.008 |
0.322 |
|
| 2019 |
Bader-Meunier B, Gitiaux C, Charuel J, Fabien N, Melki I, Quartier P, Belot A, Streichenberger N, Bodemer C, Aussy A, Boyer O. Ab0935 Anti-Tif-1 G-Antibodies In Juvenile Dermatomyositis Are Associated With Various Clinical Phenotypes Annals of the Rheumatic Diseases. 78: 1933-1934. DOI: 10.1136/Annrheumdis-2019-Eular.3358 |
0.312 |
|
| 2019 |
Maho-Vaillant M, Pérals C, Golinski M, Hébert V, Riou G, Boyer O, Viguier M, Calbo S, Fazilleau N, Joly P. 018 Evolution of autoreactive B and T cells in pemphigus patients with Rituximab or corticosteroida regimen treatment Journal of Investigative Dermatology. 139: S217. DOI: 10.1016/J.Jid.2019.07.021 |
0.342 |
|
| 2018 |
Bergua C, Chiavelli H, Allenbach Y, Arouche-Delaperche L, Arnoult C, Bourdenet G, Jean L, Zoubairi R, Guerout N, Mahler M, Benveniste O, Drouot L, Boyer O. pathogenicity of IgG from patients with anti-SRP or anti-HMGCR autoantibodies in immune-mediated necrotising myopathy. Annals of the Rheumatic Diseases. PMID 30309969 DOI: 10.1136/Annrheumdis-2018-213518 |
0.314 |
|
| 2018 |
Delepine CP, Derambure C, Vidal F, Pinta A, Pau D, Fraga ECdS, Boyer O, Senbel E, Gaudin P, Vittecoq O, Lequerre T. THU0020 Tocilizumab decreases the pro-inflammatory role of platelets in rheumatoid arthritis: identification of a new mechanism of action associated with positive response? Annals of the Rheumatic Diseases. 77: 238-238. DOI: 10.1136/Annrheumdis-2018-Eular.1841 |
0.315 |
|
| 2017 |
Briet C, Bourdenet G, Rogner UC, Becourt C, Tardivel I, Drouot L, Arnoult C, do Rego JC, Prevot N, Massaad C, Boyer O, Boitard C. The Spontaneous Autoimmune Neuromyopathy in ICOSL(-/-) NOD Mice Is CD4(+) T-Cell and Interferon-γ Dependent. Frontiers in Immunology. 8: 287. PMID 28424681 DOI: 10.3389/Fimmu.2017.00287 |
0.408 |
|
| 2017 |
Vaillant MM, Golinsky M, Caillot F, Hebert V, Petit M, Riou G, Boyer O, Joly P, Calbo S. 039 Autoreactive B-cells phenotype analysis in pemphigus patients before and after anti-CD20 treatment Journal of Investigative Dermatology. 137. DOI: 10.1016/J.Jid.2017.07.135 |
0.385 |
|
| 2016 |
Pérol L, Lindner JM, Caudana P, Nunez NG, Baeyens A, Valle A, Sedlik C, Loirat D, Boyer O, Créange A, Cohen JL, Rogner UC, Yamanouchi J, Marchant M, Leber XC, et al. Loss of immune tolerance to IL-2 in type 1 diabetes. Nature Communications. 7: 13027. PMID 27708334 DOI: 10.1038/Ncomms13027 |
0.306 |
|
| 2016 |
Martinet J, Bourdenet G, Meliani A, Jean L, Adriouch S, Cohen JL, Mingozzi F, Boyer O. Induction of Hematopoietic Microchimerism by Gene-Modified BMT Elicits Antigen-Specific B and T Cell Unresponsiveness toward Gene Therapy Products. Frontiers in Immunology. 7: 360. PMID 27695454 DOI: 10.3389/Fimmu.2016.00360 |
0.305 |
|
| 2016 |
Musset L, Allenbach Y, Benveniste O, Boyer O, Bossuyt X, Bentow C, Phillips J, Mammen A, Van Damme P, Westhovens R, Ghirardello A, Doria A, Choi ME, Fritzler MJ, Schmeling H, et al. Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study. Autoimmunity Reviews. PMID 27491568 DOI: 10.1016/J.Autrev.2016.07.023 |
0.317 |
|
| 2016 |
Guillou C, Fréret M, Fondard E, Derambure C, Avenel G, Golinski ML, Verdet M, Boyer O, Caillot F, Musette P, Lequerré T, Vittecoq O. Soluble alpha-enolase activates monocytes by CD14-dependent TLR4 signalling pathway and exhibits a dual function. Scientific Reports. 6: 23796. PMID 27025255 DOI: 10.1038/Srep23796 |
0.367 |
|
| 2016 |
Hardet R, Chevalier B, Dupaty L, Naïmi Y, Riou G, Drouot L, Jean L, Salvetti A, Boyer O, Adriouch S. Oral-tolerization Prevents Immune Responses and Improves Transgene Persistence Following Gene Transfer Mediated by Adeno-associated Viral Vector. Molecular Therapy : the Journal of the American Society of Gene Therapy. 24: 87-95. PMID 26265250 DOI: 10.1038/Mt.2015.146 |
0.331 |
|
| 2016 |
Fréret M, Guillou C, Fondard E, Derambure C, Avenel G, Golinski M, Verdet M, Boyer O, Caillot F, Musette P, Lequerré T, Vittecoq O. A1.32 Alpha-enolase activates monocytes by CD14-dependent TLR4 signalling pathway Annals of the Rheumatic Diseases. 75. DOI: 10.1136/Annrheumdis-2016-209124.32 |
0.354 |
|
| 2015 |
Golinski ML, Vandhuick T, Derambure C, Fréret M, Lecuyer M, Guillou C, Hiron M, Boyer O, Le Loët X, Vittecoq O, Lequerré T. Dysregulation of RasGRP1 in rheumatoid arthritis and modulation of RasGRP3 as a biomarker of TNFα inhibitors. Arthritis Research & Therapy. 17: 382. PMID 26714738 DOI: 10.1186/S13075-015-0894-9 |
0.337 |
|
| 2015 |
Kipfer S, Frigerio S, Hench J, Aussy A, Boyer O. Immune-mediated necrotising myopathy linked to statin use. Lancet (London, England). 386: e26. PMID 26074381 DOI: 10.1016/S0140-6736(15)60068-X |
0.324 |
|
| 2015 |
Rissiek B, Haag F, Boyer O, Koch-Nolte F, Adriouch S. P2X7 on Mouse T Cells: One Channel, Many Functions. Frontiers in Immunology. 6: 204. PMID 26042119 DOI: 10.3389/Fimmu.2015.00204 |
0.36 |
|
| 2015 |
Teege S, Hann A, Miksiewicz M, MacMillan C, Rissiek B, Buck F, Menzel S, Nissen M, Bannas P, Haag F, Boyer O, Seman M, Adriouch S, Koch-Nolte F. Tuning IL-2 signaling by ADP-ribosylation of CD25. Scientific Reports. 5: 8959. PMID 25753532 DOI: 10.1038/Srep08959 |
0.319 |
|
| 2015 |
Hofman P, Cherfils-Vicini J, Bazin M, Ilie M, Juhel T, Hébuterne X, Gilson E, Schmid-Alliana A, Boyer O, Adriouch S, Vouret-Craviari V. Genetic and pharmacological inactivation of the purinergic P2RX7 receptor dampens inflammation but increases tumor incidence in a mouse model of colitis-associated cancer. Cancer Research. 75: 835-45. PMID 25564520 DOI: 10.1158/0008-5472.Can-14-1778 |
0.343 |
|
| 2015 |
Trouvin A-, Jacquot S, Grigioni S, Curis E, Dedreux I, Roucheux A, Boulard H, Vittecoq O, Loët XL, Boyer O, Goëb V. Usefulness of monitoring of B cell depletion in rituximab-treated rheumatoid arthritis patients in order to predict clinical relapse: a prospective observational study. Clinical and Experimental Immunology. 180: 11-18. PMID 25370437 DOI: 10.1111/Cei.12481 |
0.37 |
|
| 2015 |
Rissiek B, Haag F, Boyer O, Koch-Nolte F, Adriouch S. ADP-ribosylation of P2X7: a matter of life and death for regulatory T cells and natural killer T cells. Current Topics in Microbiology and Immunology. 384: 107-26. PMID 25048544 DOI: 10.1007/82_2014_420 |
0.369 |
|
| 2015 |
Golinski M, Hiron M, Derambure C, Guillou C, Fréret M, Boyer O, Vittecoq O, Lequerré T. A2.8 TNFα influences the status of B and T cells by acting on BCR and TCR pathways via RASGRP1 and RASGRP3 proteins Annals of the Rheumatic Diseases. 74. DOI: 10.1136/Annrheumdis-2015-207259.43 |
0.379 |
|
| 2014 |
Allenbach Y, Drouot L, Rigolet A, Charuel JL, Jouen F, Romero NB, Maisonobe T, Dubourg O, Behin A, Laforet P, Stojkovic T, Eymard B, Costedoat-Chalumeau N, Campana-Salort E, Tournadre A, ... ... Boyer O, et al. Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin. Medicine. 93: 150-7. PMID 24797170 DOI: 10.1097/Md.0000000000000028 |
0.301 |
|
| 2014 |
Lahaye C, Beaufrére AM, Boyer O, Drouot L, Soubrier M, Tournadre A. Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins. Joint, Bone, Spine : Revue Du Rhumatisme. 81: 79-82. PMID 23953224 DOI: 10.1016/J.Jbspin.2013.06.008 |
0.308 |
|
| 2013 |
Fréret M, Drouot L, Obry A, Ahmed-Lacheheb S, Dauly C, Adriouch S, Cosette P, Authier FJ, Boyer O. Overexpression of MHC class I in muscle of lymphocyte-deficient mice causes a severe myopathy with induction of the unfolded protein response. The American Journal of Pathology. 183: 893-904. PMID 23850081 DOI: 10.1016/J.Ajpath.2013.06.003 |
0.337 |
|
| 2013 |
Golinski M-, Hiron M, Guillou C, Derambure C, Boyer O, Loët XL, Vittecoq O, Lequerré T. AB0052 Tnfa influences rasgrp1 and rasgrp3 expression levels in pbmc, b and t cells. Annals of the Rheumatic Diseases. 72. DOI: 10.1136/Annrheumdis-2013-Eular.2375 |
0.374 |
|
| 2013 |
Trouvin A-, Jacquot S, Grigioni S, Boulard H, Dutot I, Vittecoq O, Loet XL, Boyer O, Goeb V. FRI0215 Transitional and memory b cell analysis is an essential tool to anticipate clinical relapse in rheumatoid arthritis (RA) patients treated with rituximab Annals of the Rheumatic Diseases. 72. DOI: 10.1136/Annrheumdis-2013-Eular.1342 |
0.347 |
|
| 2013 |
Guillou C, Avenel G, Derambure C, Verdet M, Golinski M, Hiron M, Adriouch S, Boyer O, Lequerré T, Vittecoq O. A2.14 Potential in Vitro Immunomodulatory Effects of the Recombinant Human Alpha-Enolase on Peripheral Blood Mononuclear Cells (PBMCs) from Healthy Donors Annals of the Rheumatic Diseases. 72. DOI: 10.1136/Annrheumdis-2013-203215.14 |
0.339 |
|
| 2013 |
Boyer O, Drouot L, Bloch-Queyrat C, Butler-Browne G, Benveniste O. SP0089 Necrotising myopathy - the new kid on the block that the old kids need to recognise Annals of the Rheumatic Diseases. 71: 22.4-22. DOI: 10.1136/Annrheumdis-2012-Eular.1564 |
0.332 |
|
| 2013 |
Allenbach Y, Rigolet A, Drouot L, Charuel JL, Jouen F, Maisonobe T, Dubourg O, Behin A, Eymard B, Laforet P, Stojkovic T, Konepaut I, Cacoub P, Kieffer P, Fain O, ... ... Boyer O, et al. P.14.11 Auto-immune necrotizing myopathies with anti-HMGCR antibodies are related to statin-exposure only for a minority of cases Neuromuscular Disorders. 23: 816-817. DOI: 10.1016/J.Nmd.2013.06.619 |
0.31 |
|
| 2013 |
Queyrat CB, Drouot L, Arouche L, Browne GB, Boyer O, Benveniste O. P.14.6 Evidence for a direct role of anti-signal recognition particle antibodies in the pathogenesis of necrotizing myopathies Neuromuscular Disorders. 23: 815. DOI: 10.1016/J.Nmd.2013.06.614 |
0.31 |
|
| 2012 |
Liao H, Franck E, Fréret M, Adriouch S, Baba-Amer Y, Authier FJ, Boyer O, Gherardi RK. Myoinjury transiently activates muscle antigen-specific CD8+ T cells in lymph nodes in a mouse model. Arthritis and Rheumatism. 64: 3441-51. PMID 22674045 DOI: 10.1002/Art.34551 |
0.421 |
|
| 2012 |
Adriouch S, Haag F, Boyer O, Seman M, Koch-Nolte F. Extracellular NAD(+): a danger signal hindering regulatory T cells. Microbes and Infection. 14: 1284-92. PMID 22634347 DOI: 10.1016/J.Micinf.2012.05.011 |
0.334 |
|
| 2012 |
Franck E, Bonneau C, Jean L, Henry JP, Lacoume Y, Salvetti A, Boyer O, Adriouch S. Immunological tolerance to muscle autoantigens involves peripheral deletion of autoreactive CD8+ T cells Plos One. 7. PMID 22570714 DOI: 10.1371/Journal.Pone.0036444 |
0.432 |
|
| 2012 |
Guillou C, Avenel G, Derambure C, Loarer FL, Verdet M, Hiron M, Maho M, Le-Loet X, Adriouch S, Sabourin JC, Boyer O, Lequerre T, Vittecoq O. Prophylactic injection of non-citrullinated α-enolase has immunomodulatory effects in collagen-induced arthritis mice Annals of the Rheumatic Diseases. 71. DOI: 10.1136/Annrheumdis-2011-201237.4 |
0.301 |
|
| 2012 |
Potier M, Vandhuick T, Hiron M, Derambure C, Boyer O, Loët XL, Vittecoq O, Lequerré T. RasGRP1 and RasGRP3 expression in lymphocytes of rheumatoid arthritis patients Annals of the Rheumatic Diseases. 71. DOI: 10.1136/Annrheumdis-2011-201236.8 |
0.382 |
|
| 2012 |
Allenbach Y, Rigolet A, Drouot L, Charuel J-, Jouen F, Maisonobe T, Stojkovic T, Cacoub P, Kieffer P, Herson S, Boyer O, Benveniste O. Première série française de myopathies nécrosantes auto-immunes associées à l’autoanticorps anti-HMGCoA réductase : la prise de statine n’est pas retrouvée pour la majorité des patients Revue De MéDecine Interne. 33. DOI: 10.1016/J.Revmed.2012.10.097 |
0.3 |
|
| 2011 |
Adriouch S, Franck E, Drouot L, Bonneau C, Jolinon N, Salvetti A, Boyer O. Improved Immunological Tolerance Following Combination Therapy with CTLA-4/Ig and AAV-Mediated PD-L1/2 Muscle Gene Transfer. Frontiers in Microbiology. 2: 199. PMID 22046170 DOI: 10.3389/Fmicb.2011.00199 |
0.316 |
|
| 2011 |
Blache C, Lequerré T, Roucheux A, Beutheu S, Dedreux I, Jacquot S, Le Loët X, Boyer O, Vittecoq O. Number and phenotype of rheumatoid arthritis patients' CD4+CD25hi regulatory T cells are not affected by adalimumab or etanercept. Rheumatology (Oxford, England). 50: 1814-22. PMID 21791546 DOI: 10.1093/Rheumatology/Ker183 |
0.755 |
|
| 2011 |
Benveniste O, Drouot L, Jouen F, Charuel JL, Bloch-Queyrat C, Behin A, Amoura Z, Marie I, Guiguet M, Eymard B, Gilbert D, Tron F, Herson S, Musset L, Boyer O. Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy. Arthritis and Rheumatism. 63: 1961-71. PMID 21400483 DOI: 10.1002/Art.30344 |
0.304 |
|
| 2010 |
Hubert S, Rissiek B, Klages K, Huehn J, Sparwasser T, Haag F, Koch-Nolte F, Boyer O, Seman M, Adriouch S. Extracellular NAD+ shapes the Foxp3+ regulatory T cell compartment through the ART2-P2X7 pathway. The Journal of Experimental Medicine. 207: 2561-8. PMID 20975043 DOI: 10.1084/Jem.20091154 |
0.414 |
|
| 2010 |
Blache C, Chauvin JM, Marie-Cardine A, Contentin N, Pommier P, Dedreux I, François S, Jacquot S, Bastit D, Boyer O. Reduced frequency of regulatory T cells in peripheral blood stem cell compared to bone marrow transplantations. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 16: 430-4. PMID 19883775 DOI: 10.1016/J.Bbmt.2009.10.027 |
0.748 |
|
| 2009 |
Blache C, Adriouch S, Calbo S, Drouot L, Dulauroy S, Arnoult C, Le Corre S, Six A, Seman M, Boyer O. Cutting edge: CD4-independent development of functional FoxP3+ regulatory T cells. Journal of Immunology (Baltimore, Md. : 1950). 183: 4182-6. PMID 19767568 DOI: 10.4049/Jimmunol.0901678 |
0.746 |
|
| 2009 |
Lemoine FM, Cherai M, Giverne C, Dimitri D, Rosenzwajg M, Trebeden-Negre H, Chaput N, Barrou B, Thioun N, Gattegnio B, Selles F, Six A, Azar N, Lotz JP, Buzyn A, ... ... Boyer O, et al. Massive expansion of regulatory T-cells following interleukin 2 treatment during a phase I-II dendritic cell-based immunotherapy of metastatic renal cancer. International Journal of Oncology. 35: 569-81. PMID 19639177 DOI: 10.3892/Ijo_00000368 |
0.309 |
|
| 2008 |
Calbo S, Delagrèverie H, Arnoult C, Authier FJ, Tron F, Boyer O. Functional tolerance of CD8+ T cells induced by muscle-specific antigen expression. Journal of Immunology (Baltimore, Md. : 1950). 181: 408-17. PMID 18566407 DOI: 10.4049/Jimmunol.181.1.408 |
0.398 |
|
| 2008 |
Marie-Cardine A, Divay F, Dutot I, Green A, Perdrix A, Boyer O, Contentin N, Tilly H, Tron F, Vannier JP, Jacquot S. Transitional B cells in humans: characterization and insight from B lymphocyte reconstitution after hematopoietic stem cell transplantation. Clinical Immunology (Orlando, Fla.). 127: 14-25. PMID 18191619 DOI: 10.1016/J.Clim.2007.11.013 |
0.326 |
|
| 2008 |
Coquerel Q, Nilsson I, Blache C, Ibrahim A, Sinno MH, Johansen J, Adriouch S, Boyer O, Hökfelt T, Dechelotte P, Fetissov S. Effect of post-neonatal thymectomy on body weight gain in Swiss mice: The role of regulatory T-cells and the hypothalamic arcuate nucleus Appetite. 51: 359. DOI: 10.1016/J.Appet.2008.04.059 |
0.73 |
|
| 2006 |
Jacquot S, Boyer O. [Heterogeneity and function of human B lymphocytes]. Medecine Sciences : M/S. 22: 1075-80. PMID 17156729 DOI: 10.1051/Medsci/200622121075 |
0.399 |
|
| 2006 |
Cohen JL, Boyer O. The role of CD4+CD25hi regulatory T cells in the physiopathogeny of graft-versus-host disease Current Opinion in Immunology. 18: 580-585. PMID 16879951 DOI: 10.1016/J.Coi.2006.07.007 |
0.39 |
|
| 2006 |
Dimitri D, Benveniste O, Dubourg O, Maisonobe T, Eymard B, Amoura Z, Jean L, Tiev K, Piette JC, Klatzmann D, Herson S, Boyer O. Shared blood and muscle CD8+ T-cell expansions in inclusion body myositis. Brain : a Journal of Neurology. 129: 986-95. PMID 16455793 DOI: 10.1093/Brain/Awl020 |
0.417 |
|
| 2006 |
Barcia C, Thomas C, Curtin JF, King GD, Wawrowsky K, Candolfi M, Xiong W, Chunyan L, Kroeger K, Boyer O, Kupiec-Weglinski J, Klatzmann D, Castro MG, Lowenstein PR. 999. Mature Effector Immunological Synapses Forming SMAC Mediate Clearance of Virally Infected Astrocytes from the Brain In Vivo Molecular Therapy. 13: S385. DOI: 10.1016/J.Ymthe.2006.08.1092 |
0.33 |
|
| 2006 |
Vittecoq O, Serna T, Dutot I, Jacquot S, Loët XL, Tron F, Boyer O. Augmentation du nombre de lymphocytes T CD4+ CD25high sous adalimumab, mais non sous etanercept, dans la polyarthrite rhumatoïde - Résultats préliminaires Revue Du Rhumatisme. 73: 1095. DOI: 10.1016/J.Rhum.2006.10.180 |
0.387 |
|
| 2005 |
Barcia C, Thomas C, Curtin JF, Zirger JM, Xiong W, Boyer O, Klatzmann D, Castro MG, Lowenstein PR. 946. CD8+ T Cells Are Partially Mediate the Immune-Mediated Silencing of Adenoviral Vector-Encoded Transgene Expression in the Rat Brain Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.489 |
0.371 |
|
| 2004 |
Benveniste O, Squier W, Boyer O, Hilton-Jones D, Herson S. [Pathogenesis of primary inflammatory myopathies]. Presse Medicale (Paris, France : 1983). 33: 1444-50. PMID 15611679 DOI: 10.1016/S0755-4982(04)98952-X |
0.317 |
|
| 2004 |
GarcÃa de la Peña-Lefebvre P, Chanseaud Y, Tamby MC, Reinbolt J, Batteux F, Allanore Y, Kahan A, Meyer O, Benveniste O, Boyer O, Guillevin L, Boissier MC, Mouthon L. IgG reactivity with a 100-kDa tissue and endothelial cell antigen identified as topoisomerase 1 distinguishes between limited and diffuse systemic sclerosis patients. Clinical Immunology (Orlando, Fla.). 111: 241-51. PMID 15183145 DOI: 10.1016/J.Clim.2004.01.005 |
0.309 |
|
| 2003 |
Misra N, Bayry J, Pashov A, Kaveri SV, D'Oiron R, Stieltjes N, Roussel-Robert V, Kazatchkine MD, Boyer O, Lacroix-Desmazes S. Restricted BV gene usage by factor VIII-reactive CD4+ T cells in inhibitor-positive patients with severe hemophilia A. Thrombosis and Haemostasis. 90: 813-22. PMID 14597975 DOI: 10.1160/TH03-05-0300 |
0.322 |
|
| 2003 |
Saadoun D, Boyer O, Abriol J, Guise L, Piette JC, Klatzman D, Cacoub P. Expansions oligoclonales de lymphocytes T CD4+ activés dans les vascularites cryoglobulinémiques liées au virus de l'hépatite C Revue De MéDecine Interne. 24: 417. DOI: 10.1016/S0248-8663(03)80406-X |
0.34 |
|
| 2003 |
Saadoun D, Boyer O, Abriol J, Dodille M, Thibaut V, Piette JC, Klatzman D, Cacoub P. Déficit en lymphocytes T régulateurs CD4+CD25+ dans les vascularites cryoglobulinémiques associées au virus de l'hépatite C Revue De MéDecine Interne. 24: 416. DOI: 10.1016/S0248-8663(03)80405-8 |
0.354 |
|
| 2001 |
Benveniste O, Chérin P, Maisonobe T, Merat R, Chosidow O, Mouthon L, Guillevin L, Flahault A, Burland MC, Klatzmann D, Herson S, Boyer O. Severe perturbations of the blood T cell repertoire in polymyositis, but not dermatomyositis patients. Journal of Immunology (Baltimore, Md. : 1950). 167: 3521-9. PMID 11544346 DOI: 10.4049/Jimmunol.167.6.3521 |
0.429 |
|
| 2000 |
Cohen JL, Saron M, Boyer O, Thomas-Vaslin V, Bellier B, Lejeune L, Charlotte F, Klatzmann D. Preservation of graft-versus-infection effects after suicide gene therapy for prevention of graft-versus-host disease Human Gene Therapy. 11: 2473-2481. PMID 11119419 DOI: 10.1089/10430340050207966 |
0.335 |
|
| 2000 |
Movassagh M, Boyer O, Burland MC, Leclercq V, Klatzmann D, Lemoine FM. Retrovirus-mediated gene transfer into T cells: 95% transduction efficiency without further in vitro selection Human Gene Therapy. 11: 1189-1200. PMID 10834620 DOI: 10.1089/10430340050015239 |
0.415 |
|
| 1998 |
Cohen JL, Boyer O, Salamon B, Onclercq R, Depetris D, Lejeune L, Dubus-Bonnet V, Bruel S, Charlotte F, Mattei M, Klatzmann D. Fertile Homozygous Transgenic Mice Expressing a Functional Truncated Herpes Simplex Thymidine Kinase ΔTK Gene Transgenic Research. 7: 321-330. PMID 9859221 DOI: 10.1023/A:1008893206208 |
0.316 |
|
| 1997 |
Cohen JL, Boyer O, Salomon B, Onclercq R, Charlotte F, Bruel S, Boisserie G, Klatzmann D. Prevention of Graft-Versus-Host Disease in Mice Using a Suicide Gene Expressed in T Lymphocytes Blood. 89: 4636-4645. DOI: 10.1182/Blood.V89.12.4636 |
0.371 |
|
| Show low-probability matches. |